Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.3.2 updated from v3.3.1; this is a minor site version change with no impact on study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision label at the bottom of the page footer updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedA site-wide banner about potential delays due to government funding and NIH operating status has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check43 days agoChange DetectedThe two screenshots show only cosmetic/layout differences with no substantive changes to the study details, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check72 days agoChange DetectedMajor update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.SummaryDifference3%

- Check79 days agoChange Detected- Page revision updated from v3.0.2 to v3.1.0. - Indicates a new software release/version of the page, with no other substantive content changes evident.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.